CNCR vs. VHT

Last updated Jun 3, 2026

CNCR (Loncar Cancer Immunotherapy ETF) and VHT (Vanguard Health Care ETF) are both Health & Biotech Equities funds - CNCR tracks the Loncar Cancer Immunotherapy Index while VHT tracks the MSCI US Investable Market Health Care 25/50 Index. Both are passively managed. CNCR charges 0.79%/yr vs 0.10%/yr for VHT.

Performance

CNCR vs. VHT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Loncar Cancer Immunotherapy ETF (CNCR) and Vanguard Health Care ETF (VHT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

VHT

• 1D: -1.21%
• 1M: 0.62%
• YTD: -4.81%
• 6M: -4.41%
• 1Y: 13.73%
• 3Y*: 5.85%
• 5Y*: 4.42%
• 10Y*: 9.17%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CNCR vs. VHT - Yearly Performance Comparison

	2026 (YTD)
CNCR Loncar Cancer Immunotherapy ETF	0.00%
VHT Vanguard Health Care ETF	-5.91%

CNCR vs. VHT - Sectors Allocation Comparison

Sectors	CNCR	VHT
Healthcare	96.6%	100.0%
Financial Services	3.3%	0.0%
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Industrials	-	0.0%
Real Estate	-	-
Technology	-	0.0%
Utilities	-	-

Return for Risk

CNCR vs. VHT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VHT

VHT Risk / Return Rank: 27
VHT Sharpe Ratio Rank: 27
VHT Sortino Ratio Rank: 28
VHT Omega Ratio Rank: 25
VHT Calmar Ratio Rank: 28
VHT Martin Ratio Rank: 25

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CNCR vs. VHT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Loncar Cancer Immunotherapy ETF (CNCR) and Vanguard Health Care ETF (VHT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	CNCR	VHT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	0.96	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.30	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.54	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.56	—

Drawdowns

CNCR vs. VHT - Drawdown Comparison

The maximum CNCR drawdown since its inception was 0.00%, smaller than the maximum VHT drawdown of -39.12%. Use the drawdown chart below to compare losses from any high point for CNCR and VHT.

Drawdown Indicators

	CNCR	VHT	Difference
Max Drawdown Largest peak-to-trough decline	0.00%	-39.12%	+39.12%
Max Drawdown (1Y) Largest decline over 1 year	—	-10.40%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-16.91%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-17.71%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-28.85%	—
Current Drawdown Current decline from peak	0.00%	-7.83%	+7.83%
Average Drawdown Average peak-to-trough decline	0.00%	-5.99%	+5.99%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	4.12%	—

Volatility

Volatility by Period

	CNCR	VHT	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	4.00%	—
Volatility (6M) Calculated over the trailing 6-month period	—	10.14%	—
Volatility (1Y) Calculated over the trailing 1-year period	0.00%	14.32%	-14.32%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	0.00%	14.96%	-14.96%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	0.00%	16.94%	-16.94%

CNCR vs. VHT - Expense Ratio Comparison

CNCR has a 0.79% expense ratio, which is higher than VHT's 0.10% expense ratio.

Dividends

CNCR vs. VHT - Dividend Comparison

CNCR has not paid dividends to shareholders, while VHT's dividend yield for the trailing twelve months is around 1.72%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CNCR Loncar Cancer Immunotherapy ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
VHT Vanguard Health Care ETF	1.72%	1.61%	1.53%	1.36%	1.33%	1.14%	1.21%	1.89%	1.38%	1.31%	1.45%	1.22%

Frequently Asked Questions

Which ETF is better, CNCR or VHT?

On fees, VHT is cheaper at 0.10% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, CNCR or VHT?

VHT is cheaper with a 0.10% expense ratio, compared with 0.79% for CNCR.

Which ETF pays a higher dividend yield, CNCR or VHT?

VHT has the higher dividend yield at 1.72%, compared with 0.00% for CNCR.

What is the main difference between CNCR and VHT?

CNCR tracks Loncar Cancer Immunotherapy Index, while VHT tracks MSCI US Investable Market Health Care 25/50 Index. They also come from different issuers: Exchange Traded Concepts and Vanguard. Their fees differ too: 0.79% for CNCR and 0.10% for VHT.